Marios Giannakis, Dana-Farber Cancer Institute (IMAGE)
Caption
Colorectal cancers heavily bedecked with tumor-related proteins called neoantigens are likely to be permeated with disease-fighting white blood cells, researchers at Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard report in a new study.
Credit
Dana-Farber Cancer Institute
Usage Restrictions
None
License
Licensed content